Expanded umbilical cord lining mesenchymal stem cell therapy (University of Colorado)

N/A

Report date: 2023/01/12 15:30:03

Base Information

Drug NameExpanded umbilical cord lining mesenchymal stem cell therapy (University of Colorado)
Drug Alias NameCorlicyte
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCellresearch CorpUniversity Of Colorado At Denver
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Colorado Denver
Inactive CompaniesN/A
Active IndicationsDiabetic Foot
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A